102169-99-3

Basic information

• Product Name: 2-broMo-4-Methyl-5-nitrobenzenaMine
• Synonyms: 2-broMo-4-Methyl-5-nitrobenzenaMine;2-BroMo-4-Methyl-5-nitro-phenylaMine;BenzenaMine, 2-broMo-4-Methyl-5-nitro-
• CAS NO: 102169-99-3
• Molecular Formula: C₇H₇BrN₂O₂
• Molecular Weight: 231.04668
• Mol File: 102169-99-3.mol
• Article Data: 4

Chemical Properties

• Melting Point: 119-120 °C(Solv: ethyl acetate (141-78-6); hexane (110-54-3))
• Boiling Point: 336.8±37.0 °C(Predicted)
• Appearance: /
• Density: 1.698±0.06 g/cm3(Predicted)
• Storage Temp.: Keep in dark place,Sealed in dry,Room Temperature
• PKA: 0.98±0.10(Predicted)
• CAS DataBase Reference: 2-broMo-4-Methyl-5-nitrobenzenaMine(CAS DataBase Reference)
• NIST Chemistry Reference: 2-broMo-4-Methyl-5-nitrobenzenaMine(102169-99-3)
• EPA Substance Registry System: 2-broMo-4-Methyl-5-nitrobenzenaMine(102169-99-3)

Safety Data

• Hazardous Substances Data: 102169-99-3(Hazardous Substances Data)

Usage

General Description

2-Bromo-4-Methyl-5-Nitrobenzenamine is a chemical compound with the formula C7H7BrN2O2. It is a nitro-substituted aniline derivative that contains a bromine atom attached to the benzene ring. 2-broMo-4-Methyl-5-nitrobenzenaMine is used as an intermediate in the synthesis of various pharmaceuticals, dyes, and other organic compounds. It is also used in the production of agrochemicals and as a reagent in organic chemical reactions. 2-Bromo-4-Methyl-5-Nitrobenzenamine is a yellow crystalline solid and is mainly used in the research and development of new materials and compounds with potential industrial and pharmaceutical applications.

Upstream product

• 412935-32-1 2-bromo-4-methyl-5-nitroformanilide 
• 7664-93-9 sulfuric acid 
• 5411-53-0 5-bromo-2,4-dinitro-toluene 
• 583-68-6 2-bromo-p-toluidine 

Downstream Products

• 412935-32-1 2-bromo-4-methyl-5-nitroformanilide 
• 16503-61-0 acetic acid-(2-bromo-4-methyl-5-nitro-anilide) 
• 101580-70-5 4,5-dibromo-2-nitro-toluene 

Relevant articles and documents

AMINOPYRAZOLE DERIVATIVES

An objective of the present invention is to provide low-molecular-weight compounds that can inhibit Src family kinases. The present invention relates to compounds represented by general formula (I) or pharmacologically acceptable salts thereof. In the formula, Ar1 is optionally substituted C6-10 arylene or 5- to 10-membered heteroarylene, and Ar2 is optionally substituted C6-10 aryl or 5- to 10-membered heteroaryl. R1 and R2 are defined as described in the specification.

Photochromic properties of ortho-methylnitrobenzothiazoles in Solution

Isomeric benzothiazoles having the nitro and methyl groups ortho to each other are converted into tautomeric aci-nitro derivatives on irradiation in heptane solution; in water, the corresponding more deeply colored anions are formed. The efficiency of pho